Active Funding Opportunity Announcements (FOAs) for All NICHD

NICHD issues and participates in various FOAs to support research activities and training.

Investigator-Initiated (Unsolicited) Projects

To submit unsolicited or investigator-initiated applications, use the appropriate NIH Parent Announcement.

Active FOAs for NICHD

Please note: The following FOAs are sorted by date, from most recent to oldest. Select a table heading to change how to sort and display the FOAs.

Announcement Number Submissions Date(s) Expiration Date Activity Code(s) Title Sort descending
PAR-19-133 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

The first standard application due date for this FOA is February 25, 2019.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
January 8, 2021 R15 Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required)
PAR-18-714 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. May 8, 2021 R15 Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
PAR-19-163 Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. September 8, 2021 R21 Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)
PAR-18-747 June 14, 2018, November 14, 2018, June 14, 2019, November 14, 2019, June 15, 2020, November 13, 2020 by 5:00 PM local time of applicant organization. November 14, 2020 R01 Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R01 Clinical Trial Optional)
PAR-18-745 June 14, 2018, November 14, 2018, June 14, 2019, November 14, 2019, June 15, 2020 and November 13, 2020 by 5:00 PM local time of applicant organization. November 14, 2020 R21 Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R21 Clinical Trial Optional)
PA-20-227 October 15, 2020; January 15, 2021; April 15, 2021; October 15, 2021; January 15, 2022; April 15, 2022; October 15, 2022; January 15, 2023; April 15, 2023, by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
April 16, 2023 333 Administrative Supplement for Research on Dietary Supplements (Admin Supp-Clinical Trial Not Allowed)
PA-18-817 October 15, 2018; January 15, 2019; April 15, 2019; October 15, 2019; January 15, 2020; or April 15, 2020, by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
July 16, 2020 333 Administrative Supplements for Research on Dietary Supplements (Admin. Supp.- Clinical Trial Not Allowed)
PA-18-591 Due dates may vary by awarding IC. See the awarding IC web site for any applicable Application Due Dates. January 26, 2021 333 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional)
PAR-18-822 September 4, 2018, September 4, 2019, September 4, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
September 5, 2020 R01 Approaches for Understanding Disease Mechanisms and Improving Outcomes in TB Meningitis (TBM) (R01 Clinical Trial Not Allowed)
PAR-20-064 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
The first standard application due date for this FOA is February 16, 2020.
January 8, 2023 R03 Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed)
PAR-19-158 Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
January 8, 2022 R01 Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)
PAR-20-111 August 11, 2020, February 9, 2021,August 10, 2021,February 9, 2022,August 9, 2022, February 9, 2023 by 5:00 PM local time of applicant organization. May 8, 2023 U44 Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
PAR-20-122 ?August 11, 2020, February 9, 2021, August 10, 2021, February 9, 2022 August 9, 2022, February 9, 2023 May 8, 2023 UG3/UH3 Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
RFA-NS-19-043 New February 10, 2020, June 10, 2020, October 9, 2020; February 10, 2021; June 9, 2021; October 6, 2021; February 10, 2022; June 8, 2022; October 11, 2022
Resubmission
March 10, 2020, July 10, 2020, November 10, 2020; March 10, 2021; July 8, 2021; November 08, 2021; March 10, 2022; July 8, 2022; November 11, 2022 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
November 12, 2022 K99/R00 BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
PAR-18-813 The first due date is August 1, 2018;Standard dates apply after that, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
May 8, 2021 K99/R00 BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Clinical Trial Required)
PAR-18-814 The first due date is August 1, 2018; Standard dates apply after that, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
May 8, 2021 K99/R00 BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
RFA-NS-19-044 New February 10, 2020; June 10, 2020; October 9, 2020; February 10, 2021; June 9, 2021; October 6, 2021; February 10, 2022; June 8, 2022; October 11, 2022
Resubmission
March 10, 2020; July 10, 2020; November 10, 2020; March 10, 2021; July 8, 2021; November 08, 2021; March 10, 2022; July 8, 2022; November 11, 2022 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
November 12, 2022 K99/R00 BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required)
RFA-NS-18-023 February 23, 2018, June 21, 2018, October 22, 2018, February 21, 2019, June 21, 2019, October 21, 2019, February 21, 2020, June 22, 2020, October 21, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. October 22, 2020 UH3 BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3 - Clinical Trial Required)
RFA-NS-20-029 July 14, 2020 and June 15, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. June 16, 2021 U01 BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01 Clinical Trials Optional)
RFA-NS-18-021 February 23, 2018, June 21, 2018, October 22, 2018, February 21, 2019, June 21, 2019, October 21, 2019, February 21, 2020, June 22, 2020, October 21, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. October 22, 2020 UG3/UH3 BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 - Clinical Trial Required)
top of pageBACK TO TOP